Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness. Read More

More and more Americans are surviving cancer, and the number is expected to grow even larger in the next decade. Read More

Dozing off in front of the TV or sleeping with other lights on can affect your body’s metabolism and even lead to weight gain, according to a new study. Read More

Younger women battling advanced breast cancer may live longer by adding ribociclib to first-line endocrine therapy. Read More

Moffitt invites officials to learn from researchers and patients Read More

When artist Ray Paul was diagnosed with sarcoma in 2011, he wanted to better understand his disease. Read More

A low-fat, plant-based diet has been linked to a reduced risk of death from breast cancer. Read More

Last year, Lee was diagnosed with stage 4 metastatic lung cancer that had spread to her brain and spine. Read More

As Skin Cancer Awareness Month begins, Moffitt continues studies of deadliest form Read More

Data from Total Cancer Care® fuels research efforts. Read More

Since the approval of talimogene laherparepvec (T-VEC, Imlygic®) in 2015, Moffitt has been using this modified form of the herpes virus as a standard treatment for melanoma patients. Read More

Gail Porter was the first patient to enroll in Moffitt's rapid tissue donation program. Read More

Using oral contraceptives has been tied to a reduced risk for highly fatal aggressive ovarian cancer, according to study results presented at the American Association for Cancer Research Annual Meeting. Read More

New study attempts to estimate financial impact when cancer patients smoke. Read More

In honor of National Cancer Registrars Week, we sat down with Jennie Jones, director of the Cancer Registry at Moffitt Cancer Center. Read More

New study shows HPV vaccination rates are low among those at high risk for HIV and HPV infection. Read More

A study presented at the American Association for Cancer Research annual meeting looked at the use of PARP inhibitors as maintenance therapy for pancreatic cancer. Read More

Implementation of smoke-free policies improves health Read More

New research shows walnuts could help women who are dealing with breast cancer. Read More

Excess body weight before age 50 may be strongly associated with a higher risk of dying from pancreatic cancer than excess weight at older ages. Read More

Can a patient's response to immunotherapy be predicted? Read More

Combination chemotherapy and immunotherapy treatment shows promise in recent study. Read More

Could answers lie in genetic mutation traced to Vikings? Read More

The symposium will teach its clinical care team and healthcare providers in the community best care and practices for LGBTQ+ people with cancer. Read More

What if there was an easier way to get a glimpse into the inner working of a tumor? Read More

Join us in promoting HPV awareness and vaccination Read More

The study marks the first time an immune-system treatment has shown any benefit to glioblastoma. Read More

She leads a computational lab that models the mechanisms of interaction between tumors and their microenvironments Read More

New study shows that e-cigarettes are better than traditional nicotine-replacement therapy for smoking cessation Read More

An Israeli company says it’s discovered the cure for cancer, but Moffitt Cancer Center researchers say not so fast. Read More

Results from a new study published in the Journal of Clinical Oncology helps shape educational tools for oncologists Read More

A new report says excess body weight accounts for 7 percent of cancer cases in the United States. Read More

A 30-year study found that prostate-removal surgery added three years to the lives of men with prostate cancer, compared to those who were only monitored. Read More

More American teens are using e-cigarettes in 2018 than ever before. Read More

New drug shows promise for those battling a lower-risk form of this bone marrow cancer. Read More

Moffitt expert says obesity, drop in hysterectomies may account for rise Read More

Women who’ve given birth may be at an increased risk of breast cancer. Read More

New study shows radiation plus chemo for HPV throat cancer offers best survival odds. Read More

Promising experimental blood test spots a variety of cancers Read More

Miles for Moffitt research grants provide seed money for great ideas Read More

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive. Read More

In her own words, Dr. Dana Rollison explains why Miles for Moffitt is much more than another fundraiser. Read More

New study shows risk may be higher for those who carry Alzheimer’s gene Read More

FDA approves new drug for adults and children with rare cancers Read More

Early lung cancer usually has no symptoms, so it’s hard to detect early when there is the best chance for a cure. Read More

Moffitt’s Moonshot grant will fund efforts to help its patients quit Read More

Moffitt expert urges caution, suggests complement to conventional care Read More

Learn what Moffitt is doing bring new therapies to patients Read More

A new study suggests eating only organic fruits and veggies can reduce your risk of developing certain cancers Read More

Google Artificial Intelligence (AI) is providing a new tool to fight the disease Read More

New study suggests midlife PSA testing is key to predicting aggressive prostate cancer. Read More

New study shows daily use can reduce risk by 23 percent Read More

Read More

September 20 marks one year since the storm devastated Puerto Rico. Read More

Cancer is the second-leading cause of death worldwide, and according to the World Health Organization (WHO) cancer deaths are expected to rise to nearly 10 million this year. Read More

Behind the scenes, the Luca Lab studies the "molecular language" of cell-to-cell communication using cutting edge approaches in structural, cellular and synthetic biology. Read More

Moffitt has developed the first-ever video game that could uncover new ways to treat the disease. Read More

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program. Read More

Nearly half of the patients who participated in the trial saw their tumors shrink. Read More

Moffitt researchers use game theory to rethink cancer treatment Read More

New drug allows your T cells to go to work, destroying cancer. Read More

Summer Internship Program is part of $1.2 million grant to advance health disparity and precision medicine education and research Read More

A modified version of the virus, now used on melanoma patients, may expand to treat other cancers. Read More

Radon has been making headlines, but do you know what it is? Read More

Moffitt's High School Internship Program for Integrated Mathematical Oncology, also known as HIP-IMO, give students hands on training on how math can be used to understand, predict and treat cancer. Read More

Two new studies examined daily aspirin use for those at risk or diagnosed with the disease Read More

Study shows that a low-carb diet may raise the effectiveness of cancer-fighting drugs. Read More

A new study found wearable devices gather useful data that may help predict patient outcomes. Read More

Archeologists have uncovered six cases of cancer while studying the bodies of ancient Egyptians buried between 1,500 and 3,000 years ago. Read More

A deadly form of prostate cancer is more common that experts previously thought. Now, Moffitt is working to combat it. Read More

Patients suffering from an untreatable form of lung cancer may benefit from an existing cancer remedy that blocks cell growth. Read More

The new genetically-modified CAR T-cells seek out and destroy cancer cells expressing an FSH receptor protein found on a large number of ovarian cancer cells. Read More

Computer modeling and mathematical oncology add up to new treatment approaches at Moffitt Cancer Center Read More

A new study finds baking soda makes tumor cells easier to target with drugs. Read More

Recent studies compare hormone therapy and chemotherapy results for black and white men who have prostate cancer. Read More

Even though many people use the terms "antiperspirant" and "deodorant" interchangeably, antiperspirants are actually a subset of deodorants, and each works in a different way. Read More

This year the World Health Organization and partners celebrate World Immunization Week April 24-30 to promote awareness of the use of vaccines to protect people of all ages against disease. Read More

Consider applying SPF to your hands and feet the next time you get a mani and pedi. Read More

Is this where cancer goes to spread? A recent discovery raises new questions for cancer researchers. Read More

A new study suggests that physicians are less likely to recommend the HPV vaccine for boys. Read More

When it comes to money for cancer research, not all cancers are funded equally. Read More

Getting a second opinion for a cancer diagnosis is highly recommended, but even more so if you face triple negative breast cancer. Read More

Consider this: despite elephants massive size compared to humans, they are estimated to only have a 4.8 percent cancer mortality rate. Read More

Julie Djeu, PhD, took on the title of first research scientist at the fledgling Moffitt Cancer Center back in 1986 in part because she loves a challenge. Read More

HPV is so common that nearly everyone - men and women - will get it at some point in their lives, according to the Centers for Disease Control and Prevention. Read More

Smokers hoping to crush out their last butt might consider weaning themselves off the habit with temporary help from e-cigarettes. Read More

Dr. Kosj Yamoah, a physician-scientist, tracks his roots of studying prostate cancer disparities through his native Ghana. Read More

Patients with certain fast-progressing and deadly types of acute myeloid leukemia (AML) saw the first new drug for their disease in more than 40 years approved by the FDA. Read More

The fourth one on the list of Moffitt research developments for 2017 involves rethinking drug resistance with a strategy called adaptive therapy that links the frequency, dosage and type of chemo to the tumor’s response. Read More

The third item on the list of Moffitt research developments for 2017 involves new targets for existing cancer-fighting drugs. Read More

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More

Lung cancer is by far the leading cause of cancer death among both men and women. More than 220,000 Americans are diagnosed with lung cancer every year. Read More

What if a drug commonly used to protect bones from osteoporosis could be altered to keep out breast cancer cells? That’s the goal one Moffitt researcher is pursuing through the creation of "Smart Molecules." Read More

More than 30,000 pounds of medical and hurricane supplies, generators, food and water are on a chartered Boeing 737 headed for Puerto Rico, which was devastated by Hurricane Maria. Read More

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More

Dr. Enderling is an assistant member in the Integrated Mathematical Oncology Department. Find out what his team accomplished at Miles for Moffitt this year. Read More

Dr. Doug Cress is an associate member of the Molecular Oncology Department. Learn more about his role in Molecular Oncology and the Spark Program. Read More

From caregivers to survivors and patients - more than 5,600 participants shared one common goal at Miles for Moffitt: raising funds for cancer research to save lives and ultimately defeat cancer. Read More

"We have all had loved ones who've been touched by cancer. I remember being struck by the huge quality of life burden that cancer patients and survivors face," says Dr. Gonzalez. Read More

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More

How does math coincide with cancer treatment? The answer lies within the Integrated Mathematical Oncology Department at Moffitt Cancer Center. Read More

The health care needs of LGBTQ patients who are at risk or fighting cancer are a priority for continued research, Moffitt Cancer Center’s Gwendolyn Quinn, PhD, and Matthew Schabath, PhD, told ResearchAmerica.org prior to World Cancer Day on Feb. 4. Read More

At Moffitt Cancer Center we look at every patient’s cancer as unique. Our clinical expertise and transformational research keeps us at the forefront of personalizing cancer care. Read More

After 12 years, a significant study at Moffitt has come to an end. Read More

Moffitt Cancer Center hosted a Cancer Moonshot Summit bringing together physicians, scientists, patients, and advocates to discuss viable ways to accelerate cancer research and improve treatment. Read More

May is National Cancer Research Month, which serves as an important reminder to everyone that the key to future progress in the fight against cancer lies in the critical work that still needs to be done. Read More

Moffitt Cancer Center and the American Association for Cancer Research (AACR) hosted the Cancer Research Policy Forum in the Ted Couch Auditorium on Monday, March 7. Read More

Moffitt Eager to Play Role in Biden's 'Moon Shot' to Cure Cancer Read More